Delving into the Latest Updates on Truheal with Synapse

Overview

Basic Info

Drug Type

Synthetic peptide

Synonyms

+ [1]

Target

PKCα

Action

modulators

Mechanism

PKCα modulators(Protein kinase C alpha modulators)

Therapeutic Areas

Nervous System DiseasesCardiovascular DiseasesEndocrinology and Metabolic Disease+ [2]

Active Indication-

Inactive Indication

Diabetic foot ulcerDiabetic neuropathic ulcerVaricose Ulcer+ [1]

Originator Organization

HealOr Ltd.

Active Organization-

Inactive Organization

HealOr Ltd.

License Organization-

Drug Highest PhasePendingPhase 2

First Approval Date-

Regulation-

Login to view timeline

This multicenter, prospective, open-label, outpatient study will assess the safety and efficacy of HO/03/03 10µg applied topically once daily for up to 24 weeks in up to 100 subjects with Hard to Heal documented chronic wounds of various etiologies (pressure ulcers, diabetic ulcers, post operational wounds surgical incisions ulcers of rheumatoid arthritis and trauma wounds) of at least 4 weeks documentation.

Start Date01 Jan 2013

Sponsor / Collaborator

HealOr Ltd.

CTRI/2009/091/000546

/ RecruitingPhase 2

Safety and efficacy of HO/03/03 in the treatment of Planatar Neuropathic Diabetic Foot Ulcers.

Start Date15 Feb 2010

Sponsor / Collaborator

HealOr Ltd.

NCT00926068

/ Unknown statusPhase 2

Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers (Truheal)

A prospective, double blind, randomized, placebo controlled, outpatient, parallel group comparison trial to assess the safety and efficacy of HO/03/03 10µg versus Placebo, applied topically once daily for up to 14 weeks in at least 196 subjects diagnosed with Diabetes Mellitus and having a single target non-healing Plantar Neuropathic Diabetic Foot Ulcer.

Start Date01 Feb 2010

Sponsor / Collaborator

HealOr Ltd.

[+2]

100 Clinical Results associated with Truheal

Login to view more data

100 Translational Medicine associated with Truheal

Login to view more data

100 Patents (Medical) associated with Truheal

Login to view more data

100 Deals associated with Truheal

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Wounds and Injuries	Phase 2	Israel	HealOr Ltd.	01 Jan 2013
Diabetic foot ulcer	Phase 2	India	HealOr Ltd.	01 Feb 2010
Diabetic foot ulcer	Phase 2	United States	HealOr Ltd.	01 Feb 2010
Diabetic neuropathic ulcer	Phase 2	Israel	HealOr Ltd.	01 Jun 2006
Varicose Ulcer	Phase 2	Israel	HealOr Ltd.	01 Jun 2006

Login to view more data

Clinical Result

Indication

Phase

Evaluation

View All Results

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.

login

or

view full example data

Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.

login

or

view full example data

Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.

login

or

view full example data

Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.

login

or

view full example data

Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.

login

or

view full example data

Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

login

or

view full example data